Elevation Oncology, Inc. is an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. In March 2024, Elevations Oncologie refinanced its debt facility with existing lender, K2 HealthVentures (K2HV) The decrease in R&D expenses in the fourth quarter of 2023 was primarily due to decreased administrative costs, including directors' and officers&